Literature DB >> 20682789

p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix.

María José Ortuño1, Silvia Ruiz-Gaspà, Edgardo Rodríguez-Carballo, Antonio R G Susperregui, Ramon Bartrons, José Luis Rosa, Francesc Ventura.   

Abstract

Osterix, a zinc finger transcription factor, is specifically expressed in osteoblasts and osteocytes of all developing bones. Because no bone formation occurs in Osx-null mice, Osterix is thought to be an essential regulator of osteoblast differentiation. We report that, in several mesenchymal and osteoblastic cell types, BMP-2 induces an increase in expression of the two isoforms of Osterix arising from two alternative promoters. We identified a consensus Sp1 sequence (GGGCGG) as Osterix binding regions in the fibromodulin and the bone sialoprotein promoters in vitro and in vivo. Furthermore, we show that Osterix is a novel substrate for p38 MAPK in vitro and in vivo and that Ser-73 and Ser-77 are the regulatory sites phosphorylated by p38. Our data also demonstrate that Osterix is able to increase recruitment of p300 and Brg1 to the promoters of its target genes fibromodulin and bone sialoprotein in vivo and that it directly associates with these cofactors through protein-protein interactions. Phosphorylation of Osterix at Ser-73/77 increased its ability to recruit p300 and SWI/SNF to either fibromodulin or bone sialoprotein promoters. We therefore propose that Osterix binds to Sp1 sequences on target gene promoters and that its phosphorylation by p38 enhances recruitment of coactivators to form transcriptionally active complexes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682789      PMCID: PMC2952199          DOI: 10.1074/jbc.M110.123612

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene.

Authors:  Teresa López-Rovira; Elisabet Chalaux; Joan Massagué; Jose Luis Rosa; Francesc Ventura
Journal:  J Biol Chem       Date:  2001-11-07       Impact factor: 5.157

2.  Transcriptional mechanisms in osteoblast differentiation and bone formation.

Authors:  Kazuhisa Nakashima; Benoit de Crombrugghe
Journal:  Trends Genet       Date:  2003-08       Impact factor: 11.639

3.  BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2.

Authors:  Mi-Hye Lee; Tae-Geon Kwon; Hyo-Sang Park; John M Wozney; Hyun-Mo Ryoo
Journal:  Biochem Biophys Res Commun       Date:  2003-09-26       Impact factor: 3.575

4.  The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.

Authors:  Kazuhisa Nakashima; Xin Zhou; Gary Kunkel; Zhaoping Zhang; Jian Min Deng; Richard R Behringer; Benoit de Crombrugghe
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

5.  Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance.

Authors:  Wook-Young Baek; Benoit de Crombrugghe; Jung-Eun Kim
Journal:  Bone       Date:  2009-12-21       Impact factor: 4.398

6.  Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts.

Authors:  Ulrich Nöth; Richard Tuli; Reza Seghatoleslami; Michael Howard; Asit Shah; David J Hall; Noreen J Hickok; Rocky S Tuan
Journal:  Exp Cell Res       Date:  2003-11-15       Impact factor: 3.905

7.  Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity.

Authors:  Jose Sierra; Alejandro Villagra; Roberto Paredes; Fernando Cruzat; Soraya Gutierrez; Amjad Javed; Gloria Arriagada; Juan Olate; Maria Imschenetzky; Andre J Van Wijnen; Jane B Lian; Gary S Stein; Janet L Stein; Martin Montecino
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

8.  Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.

Authors:  J Guicheux; J Lemonnier; C Ghayor; A Suzuki; G Palmer; J Caverzasio
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

9.  Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase.

Authors:  Krishna M Sinha; Hideyo Yasuda; Madelene M Coombes; Sharon Y R Dent; Benoit de Crombrugghe
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

10.  Expression of alternatively spliced isoforms of human Sp7 in osteoblast-like cells.

Authors:  Maria-athina Milona; Julie E Gough; Alasdair J Edgar
Journal:  BMC Genomics       Date:  2003-11-07       Impact factor: 3.969

View more
  53 in total

1.  p53 inhibits SP7/Osterix activity in the transcriptional program of osteoblast differentiation.

Authors:  Natalia Artigas; Beatriz Gámez; Mónica Cubillos-Rojas; Cristina Sánchez-de Diego; José Antonio Valer; Gabriel Pons; José Luis Rosa; Francesc Ventura
Journal:  Cell Death Differ       Date:  2017-08-04       Impact factor: 15.828

2.  Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity.

Authors:  Chunxi Ge; Qian Yang; Guisheng Zhao; Hong Yu; Keith L Kirkwood; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

Review 3.  Signaling pathways affecting skeletal health.

Authors:  Pierre J Marie
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

4.  Sp7 and Runx2 molecular complex synergistically regulate expression of target genes.

Authors:  Harunur Rashid; Changyan Ma; Haiyan Chen; Hengbin Wang; Mohammad Q Hassan; Krishna Sinha; Benoit de Crombrugghe; Amjad Javed
Journal:  Connect Tissue Res       Date:  2014-08       Impact factor: 3.417

5.  The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter.

Authors:  Corinne Niger; Florence Lima; David J Yoo; Rishi R Gupta; Atum M Buo; Carla Hebert; Joseph P Stains
Journal:  Bone       Date:  2011-07-28       Impact factor: 4.398

6.  Bmp Induces Osteoblast Differentiation through both Smad4 and mTORC1 Signaling.

Authors:  Courtney M Karner; Seung-Yon Lee; Fanxin Long
Journal:  Mol Cell Biol       Date:  2017-02-01       Impact factor: 4.272

7.  Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program.

Authors:  Natalia Artigas; Carlos Ureña; Edgardo Rodríguez-Carballo; José Luis Rosa; Francesc Ventura
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

8.  MiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway.

Authors:  Li You; Wensha Gu; Lin Chen; Ling Pan; Jinyu Chen; Yongde Peng
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 9.  Genetic and molecular control of osterix in skeletal formation.

Authors:  Krishna M Sinha; Xin Zhou
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

Review 10.  Site-specific function and regulation of Osterix in tooth root formation.

Authors:  Y D He; B D Sui; M Li; J Huang; S Chen; L A Wu
Journal:  Int Endod J       Date:  2016-01-04       Impact factor: 5.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.